[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.197.66.254. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
July 17, 1981

Clinical Applicability of a Methacholine Inhalational Challenge

Author Affiliations

From the Departments of Medicine, Rhode Island Hospital (Drs Corrao and Braman) and the Veterans Administration Medical Center (Dr Myers), and the Division of Biological and Medical Sciences, Brown University (Drs Myers, Corrao, and Braman), Providence, RI.

JAMA. 1981;246(3):225-229. doi:10.1001/jama.1981.03320030017019
Abstract

Cough, dyspnea, and chest pain are symptoms common to many cardiopulmonary diseases. A comprehensive evaluation, including a history, physical examination, ECG, chest roentgenogram, and pulmonary function studies, will often yield a specific diagnosis. However, when these symptoms are intermittent, as they often are in patients with bronchial asthma, the diagnosis may not be apparent. If asthma is thought to be a diagnostic possibility, a bronchial inhalation challenge should be used to demonstrate bronchial hyperreactivity, the hallmark of asthma. The methacholine chloride inhalation challenge is a simple and useful laboratory test to diagnose bronchial hyperreactivity. We describe eight patients with a variety of clinical symptoms to demonstrate the usefulness of this test. Patients with unexplained respiratory symptoms should be considered for bronchial inhalation challenge before proceeding to more invasive diagnostic procedures.

(JAMA 1981;246:225-229)

×